Disease-related quantitation of TGF-beta3 in human aqueous humor

Growth Factors

Volumn 25, Issue 3, 2007, Pages 160-167

  Yoneda, Kazuhito ^a   Nakano, Masakazu ^a   Mori, Kazuhiko ^a   Kinoshita, Shigeru ^a   Tashiro, Kei ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Aqueous humor; Glaucoma; Guantitative ELISA; Pseudoexfoliation syndrome; TGF

Indexed keywords

ISOPROTEIN; PROTEIN ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CATARACT; CLOSED ANGLE GLAUCOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE DISEASE; HUMAN; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; PATHOGENESIS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN DETERMINATION; PSEUDOEXFOLIATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; CATARACT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXFOLIATION SYNDROME; GLAUCOMA, ANGLE-CLOSURE; GLAUCOMA, OPEN-ANGLE; HUMANS; MIDDLE AGED; PROTEIN ISOFORMS; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

EID: 36749066768     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190701723505     Document Type: Article

References (28)

1. Annes, JP, Munger, JS and Rifkin, DB (2003) Making sense of latent TGF-beta activation. J Cell Sci, 116, pp. 217-224.
2. Attisano, L. and Wrana, JL (1996) Signal transduction by members of the transforming growth factor-beta superfamily. Cytokine Growth Factor Rev, 7, pp. 327-339.
3. Beffagna, G., Occhi, G., Nava, A., Vitiello, L., Ditadi, A., Basso, C., Bauce, B., Carraro, G., Thiene, G., Towbin, JA, Danieli, GA and Rampazzo, A. (2005) Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res, 65, pp. 366-373.
4. Blobe, GC, Schiemann, WP and Lodish, HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med, 342, pp. 1350-1358.
5. Dunker, N. and Kreiglstein, K. (2000) Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur J Biochem, 267, pp. 6982-6988.
6. Ferguson, MW and O'Kane, S. (2004) Scar-free healing: From embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci, 359, pp. 839-850.
7. Gleizes, PE, Munger, JS, Nunes, I., Harpel, JG, Mazzieri, R., Noguera, I. and Rifkin, DB (1997) TGF-beta latency: Biological significance and mechanisms of activation. Stem Cells, 15, pp. 190-197.
8. Gottanka, J., Chan, D., Eichhorn, M., Lutjen-Drecoll, E. and Ethier, CR (2004) Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci, 45, pp. 153-158.
9. Gregory, DC, Phuong, LP, Yves, D. and Maureen, DO (2003) Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: Receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding. J Mol Biol, 328, pp. 1173-1183.
10. Heeschen, C., Goldmann, BU, Langenbrink, L., Matschuck, G. and Hamm, CW (1999) Evaluation of a rapid whole blood ELISA for quantification of troponin I in patients with acute chest pain. Clin Chem, 45, pp. 1789-1796.
11. Inatani, M., Tanihara, H., Katsuta, H., Honjo, M., Kido, N. and Honda, Y. (2001) Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol, 239, pp. 109-113.
12. Koliakos, GG, Schlotzer-Schrehardt, U., Konstas, AG, Bufidis, T., Georgiadis, N. and Dimitriadou, A. (2001) Transforming and insulin-like growth factors in the aqueous humour of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol, 239, pp. 482-487.
13. Kottler, UB, Junemann, AG, Aigner, T., Zenkel, M., Rummelt, C. and Schlotzer-Schrehardt, U. (2005) Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma. Exp Eye Res, 80, pp. 121-134.
14. Kropf, J., Quitte, E. and Gressner, AM (1991) Time-resolved immunofluorometric assays with measurement of a europium chelate in solution: Application for sensitive determination of fibronectin. Anal Biochem, 197, pp. 258-265.
15. Lawrence, DA (1996) Transforming growth factor-beta: A general review. Eur Cytokine Netw, 7, pp. 363-374.
16. Lee, S. and Sharma, K. (2004) The pathogenesis of fibrosis and renal disease in scleroderma: Recent insights from glomerulosclerosis. Curr Rheumatol Rep, 6, pp. 141-148.
17. Miyazono, K. (2002) Regulation of transforming growth factor-beta signaling and vascular diseases. Cornea, 21, pp. S48-S53.
18. Miyazono, K., Hellman, U., Wernstedt, C. and Heldin, CH (1988) Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. J Biol Chem, 263, pp. 6407-6415.
19. Ozbilgin, MK and Inan, S. (2003) The roles of transforming growth factor type beta3 (TGF-beta3) and mast cells in the pathogenesis of scleroderma. Clin Rheumatol, 22, pp. 189-195.
20. Picht, G., Welge-Luessen, U., Grehn, F. and Lutjen-Drecoll, E. (2001) Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol, 239, pp. 199-207.
21. Resnikoff, S., Pascolini, D., Etya'ale, D., Kocur, I., Pararajasegaram, R., Pokharel, GP and Mariotti, SP (2004) Global data on visual impairment in the year 2002. Bull World Health Organ, 82, pp. 844-851.
22. Robert, AB and Sporn, MB (1992) Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol Reprod Dev, 32, pp. 91-98.
23. Sawamura, Y. and De Tribolet, N. (1990) Immunotherapy of brain tumors. J Neurosurg Sci, 34, pp. 265-278.
24. Schlotzer-Schrehardt, U. and Naumann, GO (2006) Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol, 141, pp. 921-937.
25. Schlotzer-Schrehardt, U., Zenkel, M., Kuchle, M., Sakai, LY and Naumann, GO (2001) Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res, 73, pp. 765-780.
26. Sela, C., Helen, H., Marikki, L., Peter, TD, Kenneth, KI and Joan, M. (1990) Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. J Biol Chem, 265, pp. 20533-20538.
27. Tripathi, RC, Li, J., Chan, WF and Tripathi, BJ (1994) Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res, 59, pp. 723-727.
28. Tsakas, S. and Goumenos, DS (2006) Accurate measurement and clinical significance of urinary transforming growth factor-beta1. Am J Nephrol, 26, pp. 186-193.